One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.5211.5211
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: Novartis (Switzerland), Oregon Health & Science University, James Cancer Hospital, Sidney Kimmel Comprehensive Cancer Center, Juravinski Cancer Centre, Academic Medical Center, University of Pennsylvania, Peter MacCallum Cancer Centre, Presbyterian Hospital, Medical University of Vienna, Hospices Civils de Lyon, Emory UniversityClinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
